Archives

  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • Ac-DEVD-CHO br Qesseveur G Petit AC Nguyen HT

    2022-06-21


    52. Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP: Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach. Neuropharmacology 105:142-153, 2016
    53. Randesi M, van den Brink W, Levran O, Yuferov V, Blanken P, van Ree JM, Ott J, Kreek MJ: Dopamine gene variants in opioid addiction: Comparison of dependent patients, nondependent users and healthy controls. Phar-macogenomics 19:95-104, 2018
    54. Rut M, Machoy-Mokrzynska A, Reclawowicz D, Slo-niewski P, Kurzawski M, Drozdzik M, Safranow K, Moraw-ska M, Bialecka M: Influence of variation in the catechol-O-methyltransferase gene on the clinical outcome after lum-bar spine surgery for one-level symptomatic disc disease: A report on 176 cases. Acta Neurochir 156:245-252, 2014
    55. Sadhasivam S, Chidambaran V, Olbrecht VA, Esslinger HR, Zhang K, Zhang X, Martin LJ: Genetics of pain percep-tion, COMT and postoperative pain management in chil-dren. Pharmacogenomics 15:277-284, 2014
    56. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN: The Self-Administered Comorbidity Questionnaire: A new method to assess comorbidity for clinical and health serv-ices research. Arthritis Rheum 49:156-163, 2003
    57. Schreiber KL, Martel MO, Shnol H, Shaffer JR, Greco C, Viray N, Taylor LN, McLaughlin M, Brufsky A, Ahrendt G, Bovbjerg D, Edwards RR, Belfer I: Persistent pain in postmastectomy patients: Comparison of psychophysical, 
    Genetic Associations With Persistent Arm Pain
    medical, surgical, and psychosocial characteristics between patients with and without pain. Pain 154:660-668, 2013
    58. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 83:389-400, 1999
    60. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from Ac-DEVD-CHO data. Am J Hum Genet 68:978-989, 2001
    61. Tammimaki A, Mannisto PT: Catechol-O-methyltrans-ferase gene polymorphism and chronic human pain: A sys-tematic review and meta-analysis. Pharmacogenet Genomics 22:673-691, 2012
    62. Tian C, Gregersen PK, Seldin MF: Accounting for ances-
    try: Population substructure and genome-wide association studies. Hum Mol Genet 17:R143-R150, 2008
    64. van Helmond N, Steegers MA, Filippini-de Moor GP, Vissers KC, Wilder-Smith OH: Hyperalgesia and persistent pain after breast cancer surgery: A prospective randomized controlled trial with perioperative COX-2 inhibition. PLoS One 11, 2016:e0166601
    65. Vargas-Alarcon G, Fragoso JM, Cruz-Robles D, Vargas A, Vargas A, Lao-Villadoniga JI, Garcia-Fructuoso F, Ramos-Kuri M, Hernandez F, Springall R, Bojalil R, Vallejo M, Marti-nez-Lavin M: Catechol-O-methyltransferase gene haplo-types in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 9:R110, 2007
    68. Xiang X, Jiang Y, Ni Y, Fan M, Shen F, Wang X, Han J, Cui C: Catechol-O-methyltransferase polymorphisms do not play a significant role in pain perception in male Chinese Han population. Physiol Genomics 44:318-328, 2012
    www.transonc.com
    Associations Between PET Parameters and Expression of 
    Alexey Surov*, Hans Jonas Meyer* and Andreas Wienke†
    Ki-67 in Breast Cancer1,2,3 *Department of Diagnostic and Interventional Radiology,
    †Institute of Medical Epidemiology, Biostatistics, and
    Informatics, Martin-Luther-University Halle-Wittenberg,
    Abstract
    OBJECTIVES: Numerous studies investigated relationships between positron emission tomography and proliferation index Ki-67 in breast cancer (BC) with inconsistent results. The aim of the present analysis was to provide evident data about associations between standardized uptake value (SUV) and expression of Ki-67 in BC. METHODS: MEDLINE library, SCOPUS and EMBASE data bases were screened for relationships between SUV and Ki-67 in BC up to April 2018. Overall, 32 studies with 1802 patients were identified. The following data were extracted from the literature: authors, year of publication, number of patients, and correlation coefficients. Associations between SUV and Ki-67 were analyzed by Spearman's correlation coefficient. RESULTS: Associations between SUVmax derived from 18F-FDG PET and Ki-67 were reported in 25 studies (1624 patients). The pooled correlation coefficient was 0.40, (95% CI = [0.34; 0.46]). Furthermore, 7 studies analyzed associations between SUVmax derived from 18F-fluorthymidin (FLT) PET and Ki-67 (178 patients). The pooled correlation coefficient was 0.54, (95% CI = [0.37; 0.70]). CONCLUSION: SUVmax correlated moderately with expression of Ki-67 and, therefore, cannot be used as a surrogate marker for tumor proliferation. Further studies are needed to evaluate associations between PET parameters and histopathological findings like hormone receptor status in breast cancer.